Moleculin Biotech

MBRX

Börsenwert 8,02 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Vanguard Group Malvern, Pennsylvania	625.175 $	–	–	–
2	2 Sio Capital Management New York	175.602 $	-501.368 $	-95	-70 %
3	3 Geode Capital Management Boston, Massachusetts	142.645 $	–	–	–
4	4 BlackRock New York	113.558 $	-42.220 $	-8	-24 %
5	5 Renaissance Technologies New York	74.000 $	+21.110 $	+4	+31 %
6	6 Squarepoint New York	44.705 $	+36.943 $	+7	+233 %
7	7 State Street Boston, Massachusetts	41.325 $	–	–	–
8	8 Northern Trust Chicago, Illinois	31.021 $	–	–	–
9	9 Millennium Management New York	19.529 $	+21.110 $	+4	Neu
10	10 P.J. Schmidt Investment Management (PJS) Cedarburg, Wisconsin	19.012 $	+21.110 $	+4	Neu
11	11 Sigma Planning Corp Ann Arbor, Michigan	9.840 $	-31.665 $	-6	-75 %
12	12 Tower Research Capital (TRC) New York	8.323 $	–	–	–
13	13 JMAC Enterprises Newtown, Pennsylvania	7.601 $	–	–	–
14	14 Two Sigma Securities New York	7.591 $	–	–	–
15	15 Morgan Stanley New York	3.666 $	–	–	–
16	16 Royal Bank of Canada Toronto, Ontario, Canada	1.000 $	–	–	–
17	17 Osaic Holdings Scottsdale, Arizona	560 $	–	–	–
18	18 CVA Family Office Denver, Colorado	289 $	–	–	–
19	19 North Star Investment Management Chicago, Illinois	145 $	–	–	–
20	20 Wells Fargo San Francisco, California	124 $	–	–	–
21	21 Bank of America Charlotte, North Carolina	58 $	-5.278 $	-1	Geschlossen
22	22 Fidelity Investments Boston, Massachusetts	1 $	–	–	–
23	23 Citadel Advisors Miami, Florida	–	-30.649 $	-4	Geschlossen
24	24 HRT Financial New York	–	-15.000 $	-2	Geschlossen
25	25 Virtu Financial New York	–	-16.000 $	-2	Geschlossen

Moleculin Biotech MBRX Börsenwert 8,02 Mio. $

Moleculin Biotech

MBRX

Börsenwert 8,02 Mio. $